Horizon Pharma PLC (NASDAQ:HZNP)

30.82
Delayed Data
As of Apr 17
 -0.155 / -0.50%
Today’s Change
7.85
Today|||52-Week Range
31.87
+139.06%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$4.5B

Company Description

Horizon Pharma Plc is a specialty biopharmaceutical company, which engages in the business of identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. It markets a portfolio of products in arthritis, inflammation and orphan diseases. The company was founded on December 20, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Horizon Pharma Plc
Connaught House, 1st Floor
Dublin Dublin 4
P:(531) 772-2100
Investor Relations:
(224) 383-3285

Employees

Shareholders

Other institutional45.49%
Mutual fund holders24.00%
Individual stakeholders1.95%

Top Executives

Timothy P. WalbertChairman, President & Chief Executive Officer
Robert W. MetzSVP-Business Operations & Government Affairs
Paul W. HoelscherChief Financial Officer & Executive Vice President
John DevaneChief Scientific Officer & Senior Vice President
Jeffrey W. ShermanChief Medical Officer & EVP-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account